4//SEC Filing
Mack Randall 4
Accession 0001123292-17-001481
CIK 0001588972other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 6:42 PM ET
Size
15.7 KB
Accession
0001123292-17-001481
Insider Transaction Report
Form 4
Mack Randall
Senior VP, Development
Transactions
- Tax Payment
Common Stock
2017-09-28$9.04/sh−4,649$42,027→ 20,113 total - Exercise/Conversion
Common Stock
2017-09-28+15,000→ 24,762 total
Footnotes (1)
- [F1]On September 28, 2017, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 15,000 performance-based restricted stock units, which were converted into 15,000 shares of common stock on a one-for-one basis.
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeother
Related Parties
1- filerCIK 0001602336
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 6:42 PM ET
- Size
- 15.7 KB